C12N 2501/02
Compounds of the arachidonic acid pathway
Official title: Compounds of the arachidonic acid pathway, e.g. prostaglandins, leukotrienes
C12N2501/02 (Compounds of the arachidonic acid pathway) appears on 124 US grants and 225 published applications in this corpus.
Search patents in C12N- Granted patents
- 124
- Published applications
- 225
- Assignees
- 126
- Inventors
- 366
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 5 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 1 | 3 |
| 2004 | 0 | 4 |
| 2005 | 0 | 0 |
| 2006 | 0 | 9 |
| 2007 | 0 | 4 |
| 2008 | 0 | 3 |
| 2009 | 0 | 9 |
| 2010 | 2 | 6 |
| 2011 | 1 | 3 |
| 2012 | 5 | 8 |
| 2013 | 6 | 12 |
| 2014 | 5 | 19 |
| 2015 | 4 | 11 |
| 2016 | 10 | 8 |
| 2017 | 8 | 14 |
| 2018 | 13 | 16 |
| 2019 | 14 | 21 |
| 2020 | 5 | 13 |
| 2021 | 11 | 10 |
| 2022 | 8 | 13 |
| 2023 | 8 | 10 |
| 2024 | 6 | 9 |
| 2025 | 3 | 15 |
| 2026 | 1 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for producing enteric neural precursors6 Jan 2026US 12,516,288 B2Kyoto University
- Cancer-killing cells29 Jul 2025US 12,370,216 B2LIfT BioSciences Ltd
- Treatment of vasculopathy with prostacyclin and mesenchymal stem cells15 Apr 2025US 12,274,684 B2United Therapeutics Corporation
- VCN enhancer compositions and methods of using the same25 Feb 2025US 12,234,476 B2bluebird bio, Inc.
- Methods of treating cancers with CT45 targeted therapies24 Dec 2024US 12,173,042 B2Max-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V.
- Methods for the production of dendritic cells by modulating retinoid signaling6 Aug 2026US 2026/0226411 A1FUJIFILM Holdings America Corporation
- Cancer-killing cells23 Jul 2026US 2026/0207663 A2LIfT BioSciences Ltd
- Method for Manufacturing Natural Killer T (NKT) Cell-Stimulating Dendritic Cells, Method for Manufacturing Cell Compositions containing the NKT Cell Stimulating Dendritic Cells, NKT Cell, and Cell Composition Thereof30 Apr 2026US 2026/0117183 A1Riken Immune Regenerative Medicine Inc.
- Methods of producing a tumor avatar30 Apr 2026US 2026/0117192 A1Ariel Scientific Innovations Ltd.
- Vcn enhancer compositions and methods of using the same22 Jan 2026US 2026/0022403 A1bluebird bio, Inc.
Most cited
By later US patents
- Mammalian neural crest stem cells206US 5,589,376 ACalifornia Institute of Technology · 1996
- Mammalian multipotent neural stem cells159US 5,849,553 ACalifornia Institute of Technology · 1998
- Immoralized neural crest stem cells and methods of making120US 5,672,499 ACalifornia Institute of Technology · 1997
- Mammalian multipotent neural stem cells97US 5,928,947 ACalifornia Institute of Technology · 1999
- Genetically engineered mammalian neural crest stem cells87US 5,654,183 ACalifornia Institute of Technology · 1997